Breakthrough pancreatic cancer drug daraxonrasib doubled patient survival to over 13 months Early data suggests weight-loss drugs like Ozempic may reduce cancer progression by 38-50 percent Study shows skipping axillary lymph node dissection is safe for some breast cancer patients